NASH company Genfit gains dual listing via NASDAQ offering

Liver disease company Genfit gained $1.85 to $22.17 on Wednesday after the company raised a combined $135.1 million via a NASDAQ

Read the full 218 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE